The Journal of Pediatrics
Volume 153, Issue 1 , Pages 9-11, July 2008

Reduced Iron Stores and Its Effect on Vasovagal Syncope (Simple Faint)

  • Julian M. Stewart, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Julian M. Stewart, MD, PhD, Research Division and Hypotension Laboratory, New York Medical College, Suite 3050, 19 Bradhurst Ave, Hawthorne, NY 10532.

Division of Pediatric Cardiology, New York Medical College, Hawthorne, New York

Article Outline

 

Iron deficiency is extraordinarily common. Iron deficiency anemia is the single most common deficiency world wide.1 Within the vascular compartment, iron is primarily contained in hemoglobin and in storage forms such as ferritin and hemosiderin.2 Iron is also present in tissue-specific forms such as myoglobin. Less commonly considered is iron's vital role in enzymes such as the respiratory cytochromes, cytochrome P-450, nitric oxide (NO) synthases, tyrosine hydroxylase providing for catecholamine synthesis, and carotid body oxygen sensors.2 These are present throughout the blood and body and are essential for life. Such “specialized” iron increases and decreases with the amount of iron storage forms and can precede overt iron deficiency.3 A decrease in iron stores usually precedes and predicts future overt iron deficiency anemia even as early as at birth where it relates to the level of maternal iron stores.4 Decreased ferritin is the usual perinatal predictor, but its predictive ability is hampered by its role as an acute-phase reactant.5 Thus, in this issue of The Journal, Baumann-Blackmore et al6 have compared a newer tool for measuring iron status, cord blood zinc protoporphyrin/heme ratio, which is insensitive to inflammatory stimuli yet correlated with ferritin in the neonate without inflammation. Although the article does not directly relate measures of neonatal iron stores to anemia or to diminished iron stores later in life, such relationships have already been established.7 These observations offer an important and sensitive new tool to the assessment of iron stores in the neonatal period.

See related articles, p 40 and p 133

Once iron deficiency is present, what are its pathophysiological consequences? It is perhaps redundant to state that aerobic metabolism depends on the delivery of oxygenated blood to the tissues. Oxygen delivery depends on hemoglobin-oxygen carrying capacity, cardiac output and its distribution, and oxygen extraction at tissue level.8 Anemia enhances oxygen extraction through a variety of mechanisms including tissue-level hypoxia, lactate, acidosis, and CO2-mediated oxygen mobilization from hemoglobin, as well as an increase in 2,3 DPG and a shift of the oxygen dissociation curve.9 Assuming distribution and use at the tissue level remains unimpaired or even enhanced in iron deficiency, the rate at which oxygen is delivered to the tissues becomes limiting.

The reduced hemoglobin-oxygen carrying capacity of iron deficiency anemia is compensated by an increase in cardiac output.10 How this is accomplished remains incompletely understood, although metabolites such as lactate, adenosine, and hydrogen ions can produce a metaboreflex response that selectively increases sympathetic outflow to the heart, increasing contractility.11 Peripheral vasoconstriction, largely the province of the arterial baroreflex, is essentially unaffected, as is the peripheral sympathetic response to orthostasis.12 Increasing cardiac contractility by itself cannot produce much of an increase in cardiac output. Increased cardiac output in iron deficiency anemia is dependent on cardiac afterload and increased venous return to the heart. Reduced viscosity13 directly caused by decreased hematocrit cannot entirely account for the low systemic resistance observed in iron deficiency anemia.

In recent years it has been demonstrated that both non-autonomic vasodilation and structural remodeling14 with increased arterial diameter are related to increased blood flow and shear stress. This is sustained by the elaboration of substances released from the vascular endothelium, specifically NO.15 NO production is increased by shear stress. However, of greater importance, hemoglobin is the preeminent scavenger of NO.16 Cell-free hemoglobin, as might occur during hemolysis,17 functions as an almost bottomless sink for NO. However, under ordinary circumstances hemoglobin is encapsulated within red blood cells, and therefore NO removal is constrained. Iron deficiency anemia can increase nitric oxide production in adolescents18 and greatly reduce its removal by virtue of decreased hemoglobin. Iron stores also scavenge NO. Reducing iron stores by chelation also improves NO-related endothelial function.19 In particular, plasma ferritin concentrations relate directly to nitric oxide mediated vasodilation and endothelial function, even in the absence of specific hemoglobin alterations.20, 21

Which brings us to consider the article by Jarjour and Jarjour.22 They performed a retrospective study that demonstrated an association between decreased serum ferritin and simple vasovagal faint. Although most of their subjects were not overtly anemic (11% vs 0% of patients in the non-simple faint group), there was a significant increase in the prevalence of low iron storage (57% vs 17%) and marked reduction of serum ferritin (27 vs 46 μg/L). Observations of apparent efficacy of iron therapy in children with decreased iron stores and breath holding spells, which may be an infantile form of acute orthostatic intolerance, are entirely consistent with these observations. Also, erythropoietin has been used with success for years in the treatment of relatively refractory forms of orthostatic intolerance, autonomic dysfunction, and simple faint.23 This study suffers from the deficits of retrospection and from the lack of healthy volunteer control subjects. Yet it is a valuable observation, pointing to a potentially crucial and simple clinical relationship between iron deficiency and fainting and indicating a simple means by which the conditions of patients with simple faint might be improved through iron supplementation. Currently, these conclusions remain speculative.

Back to Article Outline

Scientific Significance—Simple Faint and No? 

Why is this observation scientifically important? To date, the pathophysiological cause of simple faint remains elusive.24 The authors suggest that low iron may affect the metabolism of catecholamines, or that peripheral vasodilation prevents compensatory orthostatic vasoconstriction. Neither possibility works well because resting and upright norepinephrine is proportionate to vasoconstriction in fainters25 whereas epinephrine increases in response to hypotension.26 Anemia fails to prevent effective upright vasoconstriction.12

I propose an alternate explanation: The splanchnic circulation is the single largest reservoir of blood in the body.27 Work from our laboratory28 and others29 have shown that splanchnic pooling caused by persistent and posturally resistant splanchnic vasodilation is strongly associated with orthostatic intolerance, including vasovagal faint. Evidence suggests preferential splanchnic vasodilation in anemia,30 and NO is increased whereas nitric oxide synthesis is up-regulated in simple faint31 and in other forms of orthostatic intolerance.32 Seen in this context the dual effects of vasodilation and nitric oxide excess caused by reduced iron stores with or without anemia are highly consistent with experimental observations on the nature of simple faint. The study by Jarjour and Jarjour comprises a vital connecting piece to our understanding of simple faint in otherwise “normal” adolescents.

Back to Article Outline

References 

  1. Huma N, Salim UR, Anjum FM, Murtaza MA, Sheikh MA. Food fortification strategy—preventing iron deficiency anemia: a review. Crit Rev Food Sci Nutr. 2007;47:259–265
  2. Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther. 2006;111:327–345
  3. Dallman PR. Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr. 1986;6:13–40
  4. Milman N, Backer V, Laursen EM, Graudal N, Ibsen KK, Jordal R. Serum ferritin in children and adolescents (Results from population surveys in 1979 and 1986 comprising 1312 individuals). Eur J Haematol. 1994;53:16–20
  5. Rogers JT. Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood. 1996;87:2525–2537
  6. Baumann-Blackmore NL, Goetz E, Blohowiak SE, Kling PJ. Cord blood zinc protoporphyrin/heme ratio in minority neonates at-risk for iron deficiency. J Pediatr. 2008;153:133–136
  7. Lozoff B, Kaciroti N, Walter T. Iron deficiency in infancy: applying a physiologic framework for prediction. Am J Clin Nutr. 2006;84:1412–1421
  8. Hebert PC, Van der LP, Biro G, Hu LQ. Physiologic aspects of anemia. Crit Care Clin. 2004;20:187–212
  9. Oski FA, Gottlieb AJ. The interrelationships between red blood cell metabolites, hemoglobin, and the oxygen-equilibrium curve. Prog Hematol. 1971;7:33–67
  10. Brannon ES, Merrill AJ, Warren JV, Stead EA. The cardiac output in patients with chronic anemia as measured by the technique of right atrial catheterization. J Clin Invest. 1945;24:332–336
  11. O'Leary DS, Sala-Mercado JA, Hammond RL, Ansorge EJ, Kim JK, Rodriguez J, et al. Muscle metaboreflex-induced increases in cardiac sympathetic activity vasoconstrict the coronary vasculature. J Appl Physiol. 2007;103:190–194
  12. Duke M, Abelmann WH. The hemodynamic response to chronic anemia. Circulation. 1969;39:503–515
  13. Murray JF, Escobar E, Rapaport E. Effects of blood viscosity on hemodynamic responses in acute normovolemic anemia. Am J Physiol. 1969;216:638–642
  14. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15(Suppl 3):14–18
  15. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1–21
  16. Martin W, Smith JA, White DG. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol. 1986;89:563–571
  17. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–1662
  18. Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN. Iron deficiency anemia increases nitric oxide production in healthy adolescents. Ann Hematol. 2002;81:1–6
  19. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF, et al. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001;103:2799–2804
  20. Gaenzer H, Marschang P, Sturm W, Neumayr G, Vogel W, Patsch J, et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol. 2002;40:2189–2194
  21. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Lopez-Bermejo A, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care. 2002;25:2249–2255
  22. Jarjour IT, Jarjour LK. Low iron storage in children and adolescents with neurally mediated syncope. J Pediatr. 2008;153:40–44
  23. Frishman WH, Azer V, Sica D. Drug treatment of orthostatic hypotension and vasovagal syncope. Heart Dis. 2003;5:49–64
  24. Mosqueda-Garcia R, Furlan R, Md JT, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope [In Process Citation]. Circulation. 2000;102:2898–2906
  25. Benditt DG, Ermis C, Padanilam B, Samniah N, Sakaguchi S. Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope. Europace. 2003;5:65–70
  26. Sra JS, Murthy V, Natale A, Jazayeri MR, Dhala A, Deshpande S, et al. Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope. Am J Cardiol. 1994;73:33–37
  27. Noble BJ, Drinkhill MJ, Myers DS, Hainsworth R. Reflex control of splanchnic blood volume in anaesthetized dogs. J Physiol. 1998;513(Pt 1):263–272
  28. Stewart JM, McLeod KJ, Sanyal S, Herzberg G, Montgomery LD. Relation of postural vasovagal syncope to splanchnic hypervolemia in adolescents. Circulation. 2004;110:2575–2581
  29. Tani H, Singer W, McPhee BR, Opfer-Gehrking TL, Haruma K, Kajiyama G, et al. Splanchnic-mesenteric capacitance bed in the postural tachycardia syndrome (POTS). Auton Neurosci. 2000;86:107–113
  30. Koma LM, Kirberger RM, Scholtz L, Bland-van den Berg P. Influence of normovolemic anemia on Doppler-derived blood velocity ratios of abdominal splanchnic vessels in clinically normal dogs. Vet Radiol Ultrasound. 2005;46:427–433
  31. Dietz NM, Halliwill JR, Spielmann JM, Lawler LA, Papouchado BG, Eickhoff TJ, et al. Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol. 1997;82:1785–1793
  32. Vaziri ND, Ding Y, Sangha DS, Purdy RE. Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance. J Appl Physiol. 2000;89:338–344

PII: S0022-3476(08)00202-3

doi:10.1016/j.jpeds.2008.03.010

Refers to article:

  • Low Iron Storage in Children and Adolescents with Neurally Mediated Syncope , 20 March 2008

    Imad T. Jarjour, Laila K. Jarjour
    The Journal of Pediatrics July 2008 (Vol. 153, Issue 1, Pages 40-44.e1)

  • Cord Blood Zinc Protoporphyrin/Heme Ratio in Minority Neonates at Risk for Iron Deficiency

    Nicole L. Baumann-Blackmore, Elizabeth Goetz, Sharon E. Blohowiak, Olamide Zaka, Pamela J. Kling
    The Journal of Pediatrics July 2008 (Vol. 153, Issue 1, Pages 133-136)

The Journal of Pediatrics
Volume 153, Issue 1 , Pages 9-11, July 2008